
| HOME SCHEDULE PROGRAM AUTHOR INDEX SUBJECT INDEX SIGN UP |
Genomic Maintenance & RepairMonday, October 17, 2005 3:00 PM-5:00 PM Exhibit Hall(PP311) Differential sensitivity of FancA- and FancD2-deficient cells to complex DNA double strand damage. Kachnic, Lisa*,1, Willers, Henning1, Li, Li1, Treszezamsky, Alejandro1, Powell, Simon1, 2, 1 Department of Radiation Oncology, Boston, MA, USA2 Department of Radiation Oncology, St. Louis, MO, USA ABSTRACT- Fanconi anemia (FA) is a rare hereditary chromosomal fragility disorder characterized by anemia and cancer predisposition. Cells with mutations in any of the FA genes display hypersensitivity to drugs inducing DNA interstrand crosslinks, such as mitomycin-C (MMC). Accumulating evidence suggests that FA cells are hypersensitive to a broader range of chemotherapeutic agents, which has clinical implications, since defects in the FA pathway have been detected in a wide variety of cancers. We sought to determine the sensitivity of FA cells to Tirapazamine (TPZ), which inhibits replication and topoisomerase II selectively in hypoxic tumor cells, as well as to MMC and ionizing radiation (IR). We employed isogenic pairs of human fibroblasts derived from FancA- or FancD2-deficient cells, PD220i or PD20i, respectively. Wild-type FancA or FancD2 status was reconstituted by infection with a retroviral expression vector. Clonogenic cell survival was determined in response to TPZ (under hypoxia), MMC or IR. FancA-deficient cells displayed a marked hypersensitivity to MMC (>10,000-fold reduced survival at 0.50 Key words: Fanconi anemia genes, DNA double strand damage repair, Tirapazemine, Clonogenic survival |
|
Internet Services provided by Allen Press, Inc. | 810 E. 10th St. | Lawrence, Kansas 66044 USA e-mail assystant-helpdesk@allenpress.com | Web www.allenpress.com 2005 RRS |